Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands
This study aimed at investigating the use of psychosocial interventions and psychotropic co-medication among stimulant-treated children with attention-deficit hyperactivity disorder (ADHD) in relation to the presence of psychiatric co-morbidity. Stimulant users younger than 16 years were identified in 115 pharmacies and a questionnaire was sent to their stimulant prescribing physician. Of 773 questionnaires sent out, 556 were returned and were suitable for analysis (72%). The results are based on 510 questionnaires concerning stimulant-treated children for whom a diagnosis of ADHD was reported... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2010 |
Reihe/Periodikum: | Faber , A , Kalverdijk , L J , de Jong-van den Berg , L T W , Hugtenburg , J G , Minderaa , R B & Tobi , H 2010 , ' Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands ' , European Child & Adolescent Psychiatry , vol. 19 , no. 2 , pp. 159-166 . https://doi.org/10.1007/s00787-009-0075-y |
Schlagwörter: | Stimulants / Co-morbidity / Attention deficit hyperactivity disorder / Co-medication / Multimodal treatment / ATTENTION-DEFICIT/HYPERACTIVITY DISORDER / DEFICIT-HYPERACTIVITY DISORDER / PERVASIVE DEVELOPMENTAL DISORDER / PSYCHOTROPIC MEDICATIONS / MANAGED CARE / PHARMACOTHERAPY / COMORBIDITY / SYMPTOMS / PARENTS / TRENDS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28779730 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/b2c0cd56-ba17-4554-83b5-04084007fedd |
This study aimed at investigating the use of psychosocial interventions and psychotropic co-medication among stimulant-treated children with attention-deficit hyperactivity disorder (ADHD) in relation to the presence of psychiatric co-morbidity. Stimulant users younger than 16 years were identified in 115 pharmacies and a questionnaire was sent to their stimulant prescribing physician. Of 773 questionnaires sent out, 556 were returned and were suitable for analysis (72%). The results are based on 510 questionnaires concerning stimulant-treated children for whom a diagnosis of ADHD was reported. Of the 510 children diagnosed with ADHD, 31% had also received one or more other psychiatric diagnoses, mainly pervasive developmental disorder or oppositional defiant disorder/conduct disorder. We found an association between the presence of co-morbidity and the use of psychosocial interventions for the child (P <0.001) and the parents (P <0.001). In the ADHD-only group, 26% did not receive any form of additional interventions, while psychosocial interventions varied from 8 to 18% in children with ADHD and psychiatric co-morbidity. The presence of diagnostic co-morbidity was also associated with the use of psychotropic co-medication (overall, P = 0.012) and antipsychotics (P <0.001). Stimulant-treated youths with ADHD and psychiatric co-morbidity received more psychosocial interventions and psychotropic co-medication than children with ADHD-only. The type of psychosocial interventions and psychotropic co-medication received by the children and their parents, depended on the specific co-morbid psychiatric disorder being present.